How Vernal Biosciences Helped Repair Biotechnologies Enhance mRNA Efficacy, Cut Costs and Streamline Clinical Trial Feasibility
Pioneering mRNA Therapies to Combat Hypercholesterolemia and Improve Long-Term Health Repair Biotechnologies, a preclinical biotech, is developing innovative therapies for age-related diseases such as hypercholesterolemia. Their lead asset aims to address the underlying cause of atherosclerosis, representing their ambition to…